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Recently, we observed that Staphylococcus aureus strains newly isolated from patients had twofold-higher
aconitase activity than a strain passaged extensively in vitro, leading us to hypothesize that aconitase specific
activity decreases over time during in vitro passage. To test this hypothesis, a strain recovered from a patient
with toxic shock syndrome was serially passaged for 6 weeks, and the aconitase activity was measured.
Aconitase specific activity decreased 38% (P < 0.001) by the sixth week in culture. During serial passage, S.
aureus existed as a heterogeneous population with two colony types that had pronounced (wild type) or
negligible zones of beta-hemolytic activity. The cell density-sensing accessory gene regulatory (agr) system
regulates beta-hemolytic activity. Surprisingly, the percentage of colonies with a wild-type beta-hemolytic
phenotype correlated strongly with aconitase specific activity (  0.96), suggesting a common cause of the
decreased aconitase specific activity and the variation in percentage of beta-hemolytic colonies. The loss of the
beta-hemolytic phenotype also coincided with the occurrence of mutations in the agrC coding region or the
intergenic region between agrC and agrA in the derivative strains. Our results demonstrate that in vitro growth
is sufficient to result in mutations within the agr operon. Additionally, our results demonstrate that S. aureus
undergoes significant phenotypic and genotypic changes during serial passage and suggest that vigilance
should be used when extrapolating data obtained from the study of high-passage strains.
The ability of Staphylococcus aureus to evade the host im-
mune response and cause disease is due to an extensive rep-
ertoire of known and putative virulence factors, including four
hemolysins, two lipases, several proteases, exotoxins, and en-
terotoxins. The production of many virulence factors is regu-
lated by the accessory gene regulatory (agr) operon (22, 27)
and several other global regulatory loci. The agr locus consists
of two divergently transcribed mRNAs designated RNA II and
RNA III (19). RNA II encodes a two-component regulatory
system (AgrA and AgrC) that senses the level of cyclic thio-
lactone peptides generated from agrB and agrD, also encoded
by RNA II (15). RNA III is an RNA effector molecule that
reciprocally regulates the transcription of cell-associated ad-
herence factors and secreted proteins (25). RNA III also reg-
ulates the translation of alpha-toxin mRNA (25). Transcription
of the agr operon is autoregulated by agrA in a cell density-
dependent manner and by at least two other global regulatory
proteins: the staphylococcal accessory regulator (SarA) (6) and
ArlR, the regulatory moiety of the ArlS-ArlR two-component
regulatory system (10). Recently, we determined that aconitase
affects the synthesis of several S. aureus virulence factors and
the expression of the global gene regulators RNA III and sarA
(G. A. Somerville, unpublished data). Aconitase (citrate [iso-
citrate] hydrolyase, EC 4.2.1.3) is a citric acid cycle enzyme that
converts citrate to isocitrate via a cis-aconitate intermediate.
During the course of that study, we observed that recent hu-
man isolates of S. aureus had higher aconitase activity than did
strain RN6390, which has been extensively passaged for many
years. Based on this observation, we hypothesized that aconi-
tase specific activity decreases during laboratory passage.
To test this hypothesis, a strain recovered from a patient
with toxic shock syndrome was serially passaged for 6 weeks.
Consistent with the hypothesis, aconitase activity decreased
with increasing time in culture. Inasmuch as aconitase is a
bifunctional protein with an enzymatic and regulatory function
(1, 30) and has been postulated to be a virulence factor regu-
lator (29), we also examined the effect of serial passage on
growth and virulence factor production.
MATERIALS AND METHODS
Bacterial strains and materials. All S. aureus strains used in this study have
been described, and except for strain RN6390, produce toxic shock syndrome
toxin 1 (23, 24). Strain SA564 was used for serial passage experiments. This strain
was recovered from a patient with toxic shock syndrome and is electrophoretic
type 91 (major lineage F1), an abundantly occurring virulent clone (23). It has
been passed twice in vitro prior to these studies. Bacteria were grown in tryptic
soy broth (TSB; BD Biosciences, Sparks, Md.) or on TSB containing 15 g of agar
(TSA) per liter, TSA containing 5% washed rabbit erythrocytes, or mannitol salt
agar (MSA; BD Biosciences). All cultures were grown at 37°C, and liquid cul-
tures were aerated at 225 rpm.
Serial passage. Strain SA564 was plated onto TSA and grown overnight, and
three bacterial colonies were isolated (Fig. 1). Each colony was inoculated into
a 15-ml round-bottom tube containing 3 ml of TSB. The cultures were incubated
in an environmental chamber at a 45° angle to allow for maximum aeration. Once
each day for 6 weeks the bacteria were diluted 1:200 into fresh TSB, resulting in
approximately 4 h of exponential-phase growth, 7 to 9 h of post-exponential-
phase growth, and 11 to 13 h of stationary-phase growth. Once per week an
aliquot of the bacterial culture was plated onto TSA and grown overnight, and
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individual colonies picked at random were inoculated into TSB. Bacterial cul-
tures were grown for approximately 10 h and then inoculated 1:200 (normalized
for growth) into fresh media, incubated for 12 h, and used for the determination
of the growth yield (A600), aconitase activity, and -toxin titer.
Aconitase activity assay. Cell-free lysates of S. aureus were prepared as fol-
lows. Aliquots (3.0 ml) were harvested; centrifuged; resuspended in 1.5 ml of lysis
buffer containing 90 mM Tris (pH 8.0), 100 M fluorocitrate, and 50 g of
lysostaphin (Sigma) per ml; incubated at 37°C for 10 min; and passed through a
French press (two times at 15,000 lb/in2). The lysate was centrifuged for 5 min at
14,000 rpm at 4°C, and the aconitase activity in the cell-free lysate was measured
by the method of Kennedy et al. (17).
Determination of alpha-toxin titer and the percentage of beta-hemolytic col-
onies. To determine beta-hemolytic activity, twofold serial dilutions of culture
supernatants were mixed with an equal volume of 2% washed rabbit erythrocytes
in U-bottom microtiter plates. The plates were incubated at 37°C for 30 min,
followed by incubation at 4°C overnight. The alpha-toxin titer is defined as the
inverse of the highest dilution for which 50% of the erythrocytes remain intact
after the overnight incubation (8). The percentage of beta-hemolytic colonies
was determined by plating serial dilutions of exponentially growing, serially
passaged cultures on TSA plates containing 5% washed rabbit erythrocytes.
These plates were incubated overnight at 37°C, and the total number of colonies
and the number of colonies with a beta-hemolytic phenotype were counted. For
ease of description, a colony was defined as nonhemolytic when the zone of
erythrocyte clearing was 0.5 mm from the edge of the colony.
Analysis of secreted and cell-associated proteins. Culture supernatants from
the parental strain and the three derivative strains obtained at week 6 were used
to qualitatively determine the effect of serial passage on the level of secreted
proteins. Bacteria were grown for 12 h and removed by centrifugation. The
volume of culture supernatant loaded was normalized for growth (A600), and
electrophoresis was performed on a 10% polyacrylamide gel (Bio-Rad). Protein
bands were visualized by SYPRO Ruby staining (Genomics Solutions, Chelms-
ford, Mass.). Western immunoblots were performed as described elsewhere (28)
with antibodies to -toxin (Sigma) and staphylococcal enterotoxin C (SEC;
IGEN International, Inc., Gaithersburg, Md.).
To determine protein A levels, bacteria from 12-h cultures (10 ml) were
harvested by centrifugation, washed once with phosphate-buffered saline (PBS),
resuspended in PBS (4 ml) containing 10 mM MgCl2, 50 g of lysostaphin per
ml, and 200 units of DNase. Protein concentrations were determined by the
Lowry method (20). Electrophoresis was carried out as described above with
50 g of total protein. Visualization of protein A bands was carried out with a
secondary mouse anti-immunoglobulin G antibody conjugated to horseradish
peroxidase.
Production of ROS. Bacteria (109 CFU/ml) were equilibrated with either
25 M 2,7-dihydrodichlorofluorescein (DCF) or 50 M dihydroethidine (DE)
(both from Molecular Probes, Inc., Eugene, Oreg.) for 30 to 45 min on ice.
Bacteria (108 CFU/ml) were subsequently transferred to wells of a 96-well mi-
crotiter plate, and the oxidation of DCF or DE by reactive oxygen species (ROS)
was measured at 37°C for 2 h by using a Spectramax Gemini microplate spec-
trofluorometer (Molecular Devices, Sunnyvale, Calif.). DCF fluorescence was
detected by using excitation and emission wavelengths of 485 and 538 nm,
respectively. For DE fluorescence, the excitation and emission wavelengths were
473 and 593 nm, respectively, and a cutoff filter was set at 530 nm. Fluorescence
measurements were collected once per minute, and the Vmax was calculated as
the maximum rate of fluorescence change over a 5- to 10-min period by using
Softmax Pro, version 3.1, software (Molecular Devices).
Statistical analysis. The statistical significance of physiological changes (e.g.,
aconitase activity) in the week 6 derivative strains relative to the parental strain
was assessed with the Student’s t test. To determine whether a correlation existed
between two physiological parameters, a correlation coefficient () was calcu-
lated and the percentage covariance was determined from 2.
DNA microarray analysis. S. aureus strains were grown overnight in TSB and
DNA was isolated with the Total Genomic DNA kit (Edge Biosystems, Gaith-
ersburg, Md.) according to the manufacturer’s instructions. Construction of the
S. aureus microarray and DNA hybridizations were carried out as described
earlier (9). The DNA microarray was constructed to represent only open reading
frames greater than 100 bp in length; therefore, only deletions of greater than
100 bp in length would be detected.
DNA sequence analysis. The agr operon from agrA to RNA III was amplified
by high-fidelity PCR from genomic DNA. Resultant amplicons were sequenced
by using fluorescent dye terminator chemistry from both strands with the primers
listed in Table 1. Sequence data was acquired on an Applied Biosystems 3700
automated sequencer, assembled using Sequencher (GeneCodes, Ann Arbor,
Mich.) and analyzed by using Lasergene (DNASTAR, Madison, Wis.).
RESULTS
Decreased aconitase specific activity of S. aureus during
serial passage. We recently observed that seven clonally di-
verse recent human isolates of S. aureus had at least twofold-
greater aconitase activity than the laboratory passaged strain
RN6390 (Fig. 2A). This observation led us to hypothesize that
aconitase specific activity decreased during laboratory passage.
To test this hypothesis, strain SA564 was serially passaged for
6 weeks, and the aconitase activity was measured (Fig. 2B).
The mean aconitase activity in the derivative strains varied
over the 6 weeks in culture, but after the first week it was
consistently less than the level made by the parental strain. By
the sixth week in culture, the mean aconitase activity in the
derivative strains had decreased 38% (P  0.001) relative to
the parental strain. Additionally, the depletion of endogenous
FIG. 1. In vitro serial passage experimental design. Strain SA564
was plated onto TSA and grown overnight, and three bacterial colonies
were isolated. Each colony was inoculated into a 15-ml round-bottom
tube containing 3 ml of TSB. The cultures were incubated in an
environmental chamber at a 45° angle to allow for maximum aeration.
Once each day for 6 weeks the bacteria were diluted 1:200 into fresh
TSB. Once per week an aliquot of the bacterial culture was plated onto
TSA and grown overnight, and individual colonies picked at random
were inoculated into TSB. Bacterial cultures were grown for ca. 10 h
and then inoculated 1:200 (normalized for growth) into fresh media,
incubated for 12 h, and used for the determination of growth yield
(A600), aconitase activity, and alpha-toxin titer.
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citrate in the culture medium by the derivative strains was
decreased relative to the parental strain (Fig. 2C), a finding
consistent with the decrease in aconitase activity. Taken to-
gether, these results confirm that aconitase activity decreased
significantly during serial passage.
Change in growth characteristics of S. aureus during serial
passage. Aconitase is a citric acid cycle enzyme that converts
citrate to isocitrate. Therefore, decreased aconitase activity
could detrimentally alter growth. To assess the affects of serial
passage on growth, we measured growth yields over a 6-week
time period (Fig. 3A). The growth yields of derivative strains
increased after only 1 week in serial passage and were consis-
tently higher than the parental strain throughout the growth
study. After 6 weeks of serial passage, the derivative strains
had a significantly increased mean growth yield of 2 A600 units
(2  109 CFU/ml), representing a 12% (P 	 0.012; n 	 6)
increase compared to the parental strain. However, in contrast
to the results of a previous report (4), we found no significant
change in the growth rate of the derivative strains relative to
parental strain SA564 (Fig. 4). These data indicated that in-
creased growth was due to an enhanced ability to acquire or
more efficiently utilize available nutrients during postexponen-
tial growth. An increase in cell density during in vitro growth
might also be achieved by diverting metabolites from nones-
sential functions, such as the production of secreted virulence
factors, to growth, an idea put forth previously (4, 31).
Alpha-toxin and protein A production during serial pas-
sage. Aconitase has been shown to have both an enzymatic and
regulatory function (1, 30) and has been postulated to be
involved in virulence factor regulation (29). These observa-
tions and the decreased aconitase activity present in the deriv-
ative strains led us to examine the affect of serial passage on
alpha-toxin production. The mean alpha-toxin titer of the de-
rivative strains fluctuated during serial passage but was pre-
dominantly lower relative to the parental strain (Fig. 3A). To
determine whether a correlation existed between aconitase
activity and alpha-toxin titer, the hemolytic titer was plotted as
a function of aconitase activity (data not shown), but no cor-
relation was found (2 	 1.3 %), demonstrating that aconitase
activity and alpha-toxin production are not linked. However,
FIG. 2. Aconitase activity of S. aureus isolates and serially passaged
strains. (A) Aconitase activity of clonally diverse S. aureus strains and
the highly passaged laboratory strain RN6390. Data are presented as
the average of triplicate determinations, and error bars represent the
standard deviation. (B) Mean aconitase activity of the parental strain
(SA564) and the serially passaged derivative strains over 6 weeks. The
dashed line represents a linear regression through the data and is only
intended to show the trend in the data. The data represent the mean
aconitase activity and the standard error of the mean (SEM) for the
parental strain (week 0) and three individual progeny for each week
(weeks 1 to 6). (C) Depletion of citric acid from the culture media of
the parental strain and the week 6 derivative strains. The data are
presented as the mean and SEM for three week 6 progeny, and a
representative profile for the parental strain is shown.
TABLE 1. Primers used in the sequencing of the
agr operon of strain SA564 and derivative strains
Primera Orientation Sequence (533)
AGR_1 Reverse GGAGGGGCTCACGACCAT
AGR_2 Reverse GATATCTTGTGCCATTGA
AGR_6 Reverse GAAATTGAGACCTATTAC
AGR_8 Reverse GTATCAAATTAGGCAGTG
AGR_11 Forward AAATAGGTAAGTTCACTG
AGR_12 Forward GACCTAAACCACGACCTT
AGR_13 Forward CATAATCATGTCGGAACT
AGR_17 Forward TTAAGGAAGGAGTGATTT
AGR_20 Forward ATCAATACGGCTCTACTT
AGR_21 Reverse CAACTTTTTCATCTATCA
AGR_22 Reverse GTCGCAGTATTGGTATTA
AGR_23 Reverse TTAAAATTAAACAACTCA
AGR_24 Reverse ACGCTATAATGCACATGG
AGR_25 Reverse CTAAAGTACCCGCTGAAT
AGR_26 Reverse GGCCAGTAAATAAGTAAA
a Primers used for PCR amplification of the agr locus are indicated with an
asterisk.
1432 SOMERVILLE ET AL. J. BACTERIOL.
an overlay of the mean growth yields and the mean alpha-toxin
titers suggested that the two parameters were correlated (Fig.
3A). Plotting the growth yield as a function of alpha-hemolytic
titers revealed that an inverse correlation existed between
growth yield and alpha-toxin titers (2 	 64.1%) (Fig. 2B).
Western immunoblotting confirmed a significant decrease in
the production of the secreted proteins alpha-toxin and SEC in
the week 6 derivative strains relative to the parental strain (Fig.
5). Secreted proteins are reciprocally regulated with cell-asso-
ciated proteins, including protein A, by the agr cell density-
sensing system. The level of the cell-associated protein A in-
creased concomitantly with the decrease in secreted proteins
(Fig. 5), confirming a reciprocal regulation. Taken together,
these data suggest that an alteration in cell density sensing had
occurred in the derivative strains during serial passage, an idea
consistent with previously published observations with S. au-
reus (21).
Microarray analysis of S. aureus genomic DNA. Serial pas-
sage of bacteria can result in genomic diversity of derivative
strains relative to the parental strain due to single nucleotide
changes, changes in repetitive DNA, recombination, and in-
sertion and deletion events. We used DNA microarray analysis
to screen for gene deletions that correlated with the changes in
physiology and virulence factor production in the derivative
strains. No deletions of open reading frames were found (data
not shown), demonstrating that the observed physiologic
changes are due to other genetic alterations.
Sequencing of the agr operon. Two types of nucleotide vari-
ation have been reported in the agr operon: variation that
defines an agr specificity group (13, 14) and spontaneous mu-
tations arising during genetic manipulation (21). To determine
if the variation in alpha-toxin activity that occurred during
serial passage correlated with nucleotide variation in agr, we
sequenced the agr operon in the parental strain, 18 randomly
chosen derivative strains (3 from each week of passage; beta-
hemolytic phenotype not known), and week 6 progeny for
which the beta-hemolytic phenotype was known (3 hemolytic
FIG. 3. Beta-hemolytic activity and growth yield inversely corre-
late. (A) The mean and SEM for the growth yield (A600) and beta-
hemolytic activity of the parental strain (week 0) and three individual
progeny for each week (weeks 1 to 6). (B) Plot of the growth yield as
a function of beta-hemolytic titer.
FIG. 4. Growth yields increase during serial passage but not growth
rates. (A) Growth curve of the parental strain and three week 6
progeny. (B) The post-exponential-growth phases shown in panel A
demonstrating the increase in growth yield. Note that the scale in panel
B is presented as linear. The data are presented as the mean and SEM
of three independent cultures and are representative of growth studies
performed at least twice.
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and 3 nonhemolytic). No nucleotide substitutions were present
in the agr operon of 13 of the 18 randomly chosen progeny or
the 3 beta-hemolytic colonies from the week 6 derivative
strains. In striking contrast, all three nonhemolytic week 6
derivative strains had mutations in the coding region of agrC or
in the intergenic region between agrC and agrA (Fig. 6). In
addition to mutations in these nonhemolytic strains, mutations
were identified in 5 of 18 randomly chosen derivative strains
(Fig. 6). The nonhemolytic derivative 6-2 had a point mutation
at nucleotide position 416 of the agrC coding region that re-
placed a cytidine with an adenosine, resulting in the conversion
of a serine codon (UCA) to an ochre stop codon (UAA).
Nonhemolytic derivative 6-3 had a point mutation in the in-
tergenic region between agrC and agrA, altering the predicted
agrA Shine-Dalgarno region. The third nonhemolytic week 6
derivative (6-4) had a 5-nucleotide deletion (i.e., nucleotides
89 to 93 of the agrC coding sequence) that resulted in a frame-
shift mutation generating numerous stop codons. This nucle-
otide deletion was first identified in a randomly chosen deriv-
ative strain from week 5 culture 3 (the progenitor culture of
6-4), suggesting that the mutation was stable. In addition, this
mutation increased the growth yield, thereby enhancing the
mutant’s ability to place progeny into the next generation.
Similarly, the point mutation in the nonhemolytic derivative
FIG. 5. Western blot analysis of secreted alpha-toxin and SEC and
of cell-associated protein A. Western blots of supernatants from cul-
tures of the parental strain and three week 6 progeny. The amount of
culture supernatant loaded in each lane was normalized for growth.
For the determination of protein A levels, 50 g of total protein from
cell-free lysates was loaded per lane.
FIG. 6. Mutations identified by DNA sequencing of the agr operon. (A) The numbers at the top of the figure refer to the nucleotide sequence
position relative to the agrC start codon (1), except the G 
12 A mutation, which occurs in the putative Shine-Dalgarno site, and is relative to
the agrA start site. The asterisks indicate that a particular mutation was identified more than once. (B) Summary of the nucleotide changes and predicted
outcome of the mutations identified in the agr operon. The data represent the results of DNA sequencing of the agr operon from 24 derivative
strains. The strain number is an arbitrary designation. Strains 5-1 and 5-2 were obtained from separate derivative cultures. NH, nonhemolytic.
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6-2 was also found in the randomly chosen week 5 and week 6
derivatives (5-1 and 6-1, respectively), also suggesting the mu-
tation was stable and enhanced the mutant’s ability to propa-
gate the mutation. Interestingly, all mutations were predicted
to code for a truncated or mutated AgrC or to prevent the
translation of agrA, and there was never more than one muta-
tion in any derivative strain.
Changes in the occurrence of beta-hemolytic colonies within
a population. The observed variation in the growth yield, ac-
onitase activity, and beta-hemolytic activity during serial pas-
sage suggested that the derivative strains existed as a hetero-
geneous population. To establish the extent of population
variation in a single parameter, the percentage of beta-hemo-
lytic colonies present in the culture over the 6 weeks of serial
passage was determined (Fig. 7A). The percentage of beta-
hemolytic colonies decreased by 50% during serial passage, but
a mixed population was maintained. The latter fact is surpris-
ing because the increased growth yield of nonhemolytic bacte-
ria increased their fitness (i.e., the ability to place progeny into
the next generation), suggesting that within a limited number
of in vitro serial passages the population should contain only
nonhemolytic bacteria. One possible explanation for the main-
tenance of a mixed population is that a symbiotic relationship
exists between the two populations. Interestingly, a 92.1% co-
variance between aconitase activity and the percentage of beta-
hemolytic colonies was found, confirming a strong correlation
(Fig. 7B). These data suggested a common cause for the de-
creased aconitase activity and the variation in percentage beta-
hemolytic colonies.
Changes in oxidative stress during serial passage. Aconitase
activity (i.e., the conversion of citrate to isocitrate) is mediated
by an essential redox inactive iron-sulfur center. The [4Fe-4S]
center is necessary for the binding of the C-2 carboxyl of citrate
or cis-aconitate and for the binding of the C-1 carboxyl of
isocitrate (18). This coordination of binding occurs through the
labile fourth iron atom designated Fea. In the absence of sub-
strate, the Fea of the iron-sulfur cluster is susceptible to inac-
tivation by oxygen radicals (11). The oxidative loss of the Fea
atom leads to the reversible inactivation of aconitase, leaving
the enzyme in the [3Fe-4S] state. The enzyme can be further
disassembled by loss of the remaining iron-sulfur center, thus
generating the apoaconitase form of the enzyme. This means
that aconitase can exist in three forms, [4Fe-4S], [3Fe-4S], and
apoaconitase. However, only the first form is enzymatically
active. Taken together, these data suggest that decreased ac-
onitase specific activity in the derivative strains could be the
result of a reduction in the availability of iron. However, the
media was not iron limited, leading us to measure the maxi-
mum rate (Vmax) of production of ROS by the parental strain
and the week 6 derivative strains. The rate of ROS production
by the derivative strains was significantly greater than the pa-
rental strain (11%, P 	 0.013), thus creating an intracellular
environment known to inactivate aconitase (26).
DISCUSSION
Aconitase activity and growth. Serial passage of a S. aureus
human isolate resulted in significantly decreased aconitase ac-
tivity (Fig. 2B), eventually reaching a level of activity similar to
that of the laboratory-passaged strain RN6390. A decrease in
aconitase activity would reduce the availability of citric acid
cycle intermediates for amino acid biosynthesis. Therefore, the
reduction in aconitase activity and the decreased ability of the
derivative strains to utilize citrate during passage suggests that
serial passage decreases the growth rate and/or growth yield
of the derivative strains. However, we found that the mean
growth rate of the parental and derivative strains was equiva-
lent and that the mean growth yield of the derivative strains
was significantly increased (Fig. 4). In addition to establishing
that aconitase specific activity decreased during serial passage,
these data suggested that the citric acid cycle was being used to
generate energy for virulence factor production in postexpo-
nential growth.
agr operon. Serial passage of bacteria can result in increased
genomic diversity of derivative strains relative to the parental
strain (3). Genomic diversity can result from the accumulation
of mutations, DNA deletions or insertions, or changes in re-
petitive sequences. No large deletions were found that ac-
counted for the physiologic or virulence changes in the deriv-
ative strains (data not shown). The bacterial cultures were
started from single colonies, and therefore the total DNA is
common to all bacteria in the culture. Hence, the possibility is
remote that an insertion event would result in the gain of
function (e.g., enhanced ability to acquire or utilize additional
carbon sources). Thus, it is unlikely that the phenotypic
changes occurred as a consequence of large DNA deletion or
insertion events.
Transposon mutagenesis of S. aureus has been associated
with spontaneous mutations arising in the agr operon, an ob-
FIG. 7. Determination of the percentage of beta-hemolytic colo-
nies during serial passage. (A) Examples of the rabbit blood agar plates
used for the determination of the percentage of beta-hemolytic CFU in
panel B. (B) The mean and SEM for aconitase activity and the per-
centage of beta-hemolytic CFU by the parental strain (week 0) and the
progeny (weeks 1 to 6) are plotted for the 6 weeks of serial passage.
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servation resulting in the agr operon being described as a
region of “genetic instability” (21). Our results demonstrate
that genetic manipulation alone is not required to generate
mutations in this region.
Our data revealed that all of the nucleotide changes that
occurred were predicted to yield a truncated or mutated AgrC
or to prevent the translation of agrA transcripts. All of these
mutations would be expected to inactivate quorum sensing,
producing pronounced phenotypic changes. These mutations
decreased the production of secreted virulence factors and
increased the growth yield, thereby increasing the fitness of the
agr mutants, suggesting that there was selection for these mu-
tations. However, it is reasonable to assume that some pheno-
typic differences are due to mutations in genes other than those
encoded by agr. Evidence for in vivo selection of agr mutants
has been suggested by an agr functionality screen (32). In that
study, it was found that approximately 25% of 105 recent
human isolates were deficient in the production of delta-toxin,
indicating that agr mediated regulation was disrupted.
Implications for agr variation in vivo. S. aureus can invade
epithelial cell lines resulting in apoptosis (2, 16), or it can
invade and persist intracellularly (12, 33). The organism can
also invade and survive in neutrophils, a situation believed to
contribute to the spread of infection (12). Compared to the
isogenic wild-type strain, agr mutants are internalized more
efficiently by epithelial cells in vitro, are better able to persist,
and do not induce apoptosis (33). agr-mediated cell density
sensing reciprocally regulates the expression of cell-associated
adhesion proteins and secreted virulence factors (25). There-
fore, the increased uptake and persistence are likely due to an
increase in the expression of cell-associated adhesion proteins
(e.g., fibronectin-binding protein). Taken together, these ob-
servations suggest that in certain circumstances inactivation of
agr can be advantageous to S. aureus.
During growth in aerobic conditions, mutations arise in agr
(Fig. 6), creating a mixed bacterial population (e.g., beta-
hemolytic and nonhemolytic). It is reasonable to assume that in
a mixed population of S. aureus, a percentage of the cells
express colonization factors (e.g., fibronectin-binding protein),
some express secreted virulence proteins (e.g., alpha-toxin),
some express neither, and some express both. A diverse bac-
terial population allows for mutants present in a low percent-
age under one set of environmental conditions to become the
predominant progeny following an environmental shift. Spon-
taneously arising mutations within the csrR-csrS two-compo-
nent virulence regulatory system in Streptococcus pyogenes sig-
nificantly enhance the pathogenicity of wild-type bacteria
during coinfection (7). We hypothesize, based on these obser-
vations, that mutations of agr create a mixed bacterial popu-
lation and that the ecological niche and host immune, response
select for the S. aureus agr variant(s) best able to adapt to a
particular environment.
Conclusions. Serial passage of S. aureus caused significant
phenotypic changes and alteration of the global regulator agr.
Our data demonstrate that mutations in agr result in the gen-
eration of a diverse population of bacteria. We speculate that
a diverse population of bacteria enhances the likelihood of
subsequent selection of the S. aureus agr variant(s) most capa-
ble of surviving a specific environment. Lastly, our results dem-
onstrate that caution should be used when data generated with
high-passage strains are extrapolated to low-passage, recent
clinical isolates.
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